Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal and Cancer Research

Executive Summary: Y-27632 dihydrochloride is a highly selective, small-molecule inhibitor of Rho-associated protein kinases (ROCK1 and ROCK2), exhibiting an IC₅₀ of 140 nM for ROCK1 and a K_i of 300 nM for ROCK2 under assay conditions (pH 7.4, 37°C) (APExBIO). The compound demonstrates over 200-fold selectivity against related kinases, including PKC, cAMP-dependent protein kinase, MLCK, and PAK. Its inhibition of ROCK signaling disrupts Rho-mediated stress fiber formation, cell cycle progression, and cytokinesis. Y-27632 is widely used in stem cell, cancer, and cytoskeletal research, supported by robust peer-reviewed evidence (Mouse-IL). APExBIO provides validated protocols for solubility, storage, and application, ensuring reproducibility in experimental workflows.

Biological Rationale

Rho-associated coiled-coil containing kinases (ROCK1 and ROCK2) are key mediators of the Rho/ROCK signaling pathway, regulating actin cytoskeleton organization, cell motility, and cell cycle transitions. Dysregulation of ROCK activity is implicated in tumorigenesis, metastasis, and stem cell homeostasis disruptions (FDX1-mRNA). Inhibition of ROCK kinases enables precise dissection of Rho-mediated processes in epithelial morphogenesis, cancer progression, and stem cell viability. Y-27632 dihydrochloride, by targeting ROCK1/2 with nanomolar potency, provides researchers with a validated tool to manipulate cytoskeletal architecture and cellular proliferation in vitro and in vivo (APExBIO).

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride binds the catalytic domains of ROCK1 and ROCK2, competitively inhibiting ATP binding. This prevents phosphorylation of downstream substrates such as myosin light chain (MLC), LIM kinase, and cofilin. The result is reduced actomyosin contractility, loss of stress fiber formation, and altered focal adhesion dynamics (LH-RH Acetate). Inhibition of ROCK signaling impedes cell cycle progression from G1 to S phase and disrupts cytokinesis, leading to reduced proliferation and altered cell morphology. Y-27632 is cell-permeable and active at concentrations as low as 10 μM in standard cell culture systems.

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 with an IC₅₀ of ~140 nM under in vitro kinase assay conditions (pH 7.4, 37°C) (APExBIO).
• Demonstrates >200-fold selectivity over PKC, PKA, MLCK, and PAK, confirmed in competitive kinase profiling assays (APExBIO).
• Reduces stress fiber formation and focal adhesion assembly in cultured epithelial and cancer cell lines at 10 μM (Uehata et al., 1997, PubMed).
• Enhances viability and proliferation of human pluripotent stem cells, supporting colony formation and survival post-dissociation (FDX1-mRNA).
• Suppresses tumor invasion and metastasis in mouse models of prostate and epithelial cancers, reducing pathological structures in vivo (PD-L1).
• Solubility: ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, ≥52.9 mg/mL in water at 25°C; solubility enhanced by warming or ultrasonic treatment (APExBIO).
• Stock solutions retain potency for several months at -20°C, but long-term solution storage is not recommended (AS602801).

This article provides updated, protocol-driven insights compared to this earlier review, which focused on translational 3D spheroid models, by emphasizing atomic, verifiable facts and benchmarking data for experimental reproducibility.

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is routinely used for:

• Dissecting the Rho/ROCK signaling pathway in cell proliferation and migration assays.
• Enhancing survival of dissociated stem cells and primary epithelial cultures.
• Suppressing tumor invasion and metastasis in preclinical cancer models.
• Modulating cytoskeletal architecture in mechanobiology and tissue engineering research.
• Optimizing co-culture systems and 3D organoid models (PD-L1).

The compound is valued for its high selectivity, cell permeability, and stability under standard laboratory conditions.

Common Pitfalls or Misconceptions

• Y-27632 is not a pan-kinase inhibitor; its effects are limited to ROCK1/2 with minimal off-target activity at recommended concentrations.
• Long-term storage of aqueous solutions (>1 month) leads to degradation and loss of potency—fresh solutions should be prepared for each experiment.
• Y-27632 does not promote stem cell pluripotency but enhances cell viability post-dissociation.
• Ineffective in models lacking Rho/ROCK pathway activation; alternative pathways (e.g., Rac, Cdc42) may drive phenotypes independently.
• Not suitable as a therapeutic agent; Y-27632 is strictly for research use only.

This article clarifies the validated research scope of Y-27632, whereas AS602801's feature provides scenario-driven Q&A for cell assay optimization.

Workflow Integration & Parameters

Y-27632 dihydrochloride is supplied as a solid by APExBIO (SKU A3008). For routine use:

• Dissolve in DMSO to a stock concentration of 10–100 mM; filter sterilize if needed.
• Working concentrations typically range from 1–20 μM in cell culture assays.
• Store solid compound desiccated at 4°C or below; stock solutions at -20°C for up to several months.
• Enhance solubility by warming to 37°C or using an ultrasonic bath.
• Do not store working dilutions in aqueous buffer for extended periods.

For detailed workflow optimization, see the Y-27632 dihydrochloride product page and this technical review, which complements the present article by focusing on biochemical and mechanistic insights.

Conclusion & Outlook

Y-27632 dihydrochloride remains a cornerstone reagent for dissecting Rho/ROCK signaling in cancer, stem cell, and cytoskeletal research. APExBIO's validated supply (A3008) and robust benchmark data enable reproducible, high-impact experiments. Continued advances in live-cell imaging and single-cell sequencing will further expand the utility of Y-27632 in precision cell biology.